Publications by authors named "Aditya Bele"

Claim this Profile
E
Ecdysoneless Overexpression Drives Mammary Tumorigenesis through Upregulation of C-MYC and Glucose Metabolism.
Bhopal C Mohapatra, Sameer Mirza, Aditya Bele, Channabasavaiah B Gurumurthy, Mohsin Raza

Mol Cancer Res· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Mutation in Histone H2B Represents a New Class of Oncogenic Driver.
Richard L Bennett, Aditya Bele, Eliza C Small, Christine M Will, Behnam Nabet

Cancer Discov· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mammalian ECD Protein Is a Novel Negative Regulator of the PERK Arm of the Unfolded Protein Response.
Appolinaire A Olou, Aniruddha Sarkar, Aditya Bele, C B Gurumurthy, Riyaz A Mir

Mol Cell Biol· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acetylation of Mammalian ADA3 Is Required for Its Functional Roles in Histone Acetylation and Cell Proliferation.
Shakur Mohibi, Shashank Srivastava, Aditya Bele, Sameer Mirza, Hamid Band

Mol Cell Biol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The cell cycle regulator ecdysoneless cooperates with H-Ras to promote oncogenic transformation of human mammary epithelial cells.
Aditya Bele, Sameer Mirza, Ying Zhang, Riyaz Ahmad Mir, Simon Lin

Cell Cycle· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Novel Interaction of Ecdysoneless (ECD) Protein with R2TP Complex Component RUVBL1 Is Required for the Functional Role of ECD in Cell Cycle Progression.
Riyaz A Mir, Aditya Bele, Sameer Mirza, Shashank Srivastava, Appolinaire A Olou

Mol Cell Biol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytoplasmic localization of alteration/deficiency in activation 3 (ADA3) predicts poor clinical outcome in breast cancer patients.
Sameer Mirza, Emad A Rakha, Alaa Alshareeda, Shakur Mohibi, Xiangshan Zhao, Aditya Bele

Breast Cancer Res Treat· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overexpression of a novel cell cycle regulator ecdysoneless in breast cancer: a marker of poor prognosis in HER2/neu-overexpressing breast cancer patients.
Xiangshan Zhao, Sameer Mirza, Alaa Alshareeda, Ying Zhang, Channabasavaiah Basavaraju Gurumurthy, Aditya Bele

Breast Cancer Res Treat· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast cancer subtypes: two decades of journey from cell culture to patients.
Xiangshan Zhao, Channabasavaiah Basavaraju Gurumurthy, Gautam Malhotra, Sameer Mirza, Shakur Mohibi, Aditya Bele

Adv Exp Med Biol· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis